STIM

#4006
Neuronetics, Inc. Common Stock
1.43 USD
+2.88%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
1.43
1.43
Rango anual
0.80
4.82
Cambio diario
+2.88%
Variación mensual
+5.93%
Variación en los últimos 6 meses
-51.69%
Cambio anual
-62.37%
Cierres anteriores
1.39
Abrir
1.43
Bid
Ask
Mínimo
1.43
High
1.43
Volumen
29
Ver el calendario completo

Financials

Visión general Informes Estadísticas
Trimestre Año
  • Market Capitalization 99.07 M
  • Employee 658
  • Founded 2003
  • CEO N/A
  • Website www.neurostar.com
  • Headquarter Delaware, United States
  • FIGI BBG000QX36J1
  • Industry Technology
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-2.34
Relación precio/flujo de caja
0.65

Neuronetics Inc

Neuronetics is a Malvern, PA based, publicly traded company incorporated in Delaware in April 2003, that develops non-invasive treatments for psychiatric disorders that have shown resistance or lack of improvement using traditional medicine. The treatments are based upon neuromodulation technology. Neuronetics became the "first and only Food and Drug Administration approval for the clinical treatment of a specific form of medication-refractory depression using a TMS Therapy device." They manufacture a transcranial magnetic stimulation device, NeuroStar. The NeuroStar TMS therapy is delivered via a precisely positioned magnetic coil against the patient's head.

Noticias